Chemotherapy News and Research

Latest Chemotherapy News and Research

New cancer drug shows promise to treat leukemia in mouse models

Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults.

9 Jun 2017

UAMS scientists show potential of world's smallest laser to kill single cancer cells

A University of Arkansas for Medical Sciences research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to kill single cancer cells using the world's smallest laser.

9 Jun 2017

Single chemotherapy treatment can negatively impact gait and balance, study shows

A single chemotherapy treatment can result in a significant negative impact on walking gait and balance, putting patients at an increasing risk for falls, according to a new study involving breast cancer patients conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

9 Jun 2017

SLU scientist discovers cause and potential solution for cancer-related bone pain

In a paper published in the journal Pain, Saint Louis University researcher Daniela Salvemini, Ph.D., reports discovering a key molecular pathway that drives cancer-related bone pain while providing a potential solution with a drug that already is on the market.

8 Jun 2017

Molecular biologists identify enzyme that activates and ‘supercharges’ cellular machinery

St. Jude Children's Research Hospital molecular biologists have identified an enzyme that activates and "supercharges" cellular machinery that controls how cells become specialized cells in the body.

7 Jun 2017

Chemotherapy drug effective at preventing breast cancer's return, gives patients a better quality of life

The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative regimen called CMF, when given following epirubicin.

7 Jun 2017

Combination therapy has complete response rate in children, young adults with Hodgkin lymphoma

New research presented at the American Society of Clinical Oncology 53rd Annual Meeting in Chicago shows that a previously untested combination of a monoclonal antibody-drug conjugate with a common chemotherapy agent has a high complete-response rate in children and young adults with relapsed or refractory Hodgkin lymphoma.

6 Jun 2017

Anti-nausea drug may be new treatment for obstructive sleep apnea

An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.

6 Jun 2017

Adding a second HER2-targeted treatment may improve outcomes for some women with breast cancer

A phase III clinical trial of 4,805 women with HER2-positive breast cancer suggests adding a second HER2 targeted medicine, pertuzumab (Perjeta), to standard of care trastuzumab (Herceptin) after surgery may help, although the benefit is modest.

6 Jun 2017

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

Findings from a phase III clinical trial point to a potential new treatment for patients newly diagnosed with advanced, epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC).

5 Jun 2017

Study: Cancer patients who used symptom-reporting Internet tool lived longer

Cancer patients who reported their symptoms to their cancer care providers using a web-based survey lived longer than those patients who did not, according to a study led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher.

5 Jun 2017

Study shows effectiveness of 3 months of chemotherapy in colon cancer patients after surgery

After surgery for lymph-node positive colon cancer (stage III), some patients may only need half of the long-standing standard course of chemotherapy.

5 Jun 2017

Testicular cancer survivors with low testosterone more likely to have chronic health problems

In a large study, 38% of 491 testicular cancer survivors had low testosterone levels, known as hypogonadism.

5 Jun 2017

Cannabinoids used in combination with chemotherapy found to be effective in killing leukemia cells

New research has confirmed that cannabinoids - the active chemicals in cannabis - are effective in killing leukemia cells, particularly when used in combination with chemotherapy treatments.

5 Jun 2017

Symptom self-reporting web-based tool could be used to help extend oncology patients' lives, study finds

The study funded by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) has found that a simple intervention such as a web-based tool that facilitates patients to report their symptoms in real time, triggering alerts to clinicians, can have major benefits such as longer survival.

5 Jun 2017

Electronic patient-reported symptom monitoring increases survival compared with usual cancer care

The integration of electronic patient-reported outcomes into the routine care of patients with metastatic cancer was associated with increased survival compared with usual care, according to a study published by JAMA.

5 Jun 2017

New targeted oral therapy results in durable responses across many kinds of cancer

Scientists may have developed the first targeted, oral, tumor-type agnostic therapy - a cancer medicine that works comparably well across many kinds of cancer, regardless of patient age. In clinical trials of adults and children with 17 different types of advanced cancer, larotrectinib treatment resulted in responses in 76% of patients.

5 Jun 2017

Positive results for AstraZeneca’s PARP inhibitor Lynparza in advanced breast cancer

A new study has shown that AstraZeneca's Lynparza (olaparib) can significantly slow the progress of breast cancer that is caused partially due to mutations of the culprit gene called BRCA. BRCA gene mutations are responsible for around 3% of all breast cancers. These cases of the disease that have a basis in the gene are notoriously difficult to treat and women who are tested positive for this gene may even opt for removal of their breasts before even the cancer strikes. Noted actress Angelina Jolie went for a similar prophylactic mastectomy.

5 Jun 2017

Standard therapy plus abiraterone lowers relative risk of death in men with advanced prostate cancer

A clinical trial of nearly 2,000 men shows that adding abiraterone acetate (Zytiga) to a standard initial treatment regimen for high-risk, advanced prostate cancer lowers the relative risk of death by 37%.

5 Jun 2017

Immunotherapy combination offers new hope for women with early stage triple negative breast cancer

A Yale Cancer Center clinical trial combining the immune checkpoint inhibitor (durvalumab/MEDI4736) with chemotherapy as preoperative treatment for early stage triple negative breast cancer disclosed a 71% pathologic complete response to the combination treatment in the initial phase I trial.

2 Jun 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

New cancer drug shows promise to treat leukemia in mouse models

UAMS scientists show potential of world's smallest laser to kill single cancer cells

Single chemotherapy treatment can negatively impact gait and balance, study shows

SLU scientist discovers cause and potential solution for cancer-related bone pain

Molecular biologists identify enzyme that activates and ‘supercharges’ cellular machinery

Chemotherapy drug effective at preventing breast cancer's return, gives patients a better quality of life

Combination therapy has complete response rate in children, young adults with Hodgkin lymphoma

Anti-nausea drug may be new treatment for obstructive sleep apnea

Adding a second HER2-targeted treatment may improve outcomes for some women with breast cancer

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

Study: Cancer patients who used symptom-reporting Internet tool lived longer

Study shows effectiveness of 3 months of chemotherapy in colon cancer patients after surgery

Testicular cancer survivors with low testosterone more likely to have chronic health problems

Cannabinoids used in combination with chemotherapy found to be effective in killing leukemia cells

Symptom self-reporting web-based tool could be used to help extend oncology patients' lives, study finds

Electronic patient-reported symptom monitoring increases survival compared with usual cancer care

New targeted oral therapy results in durable responses across many kinds of cancer

Positive results for AstraZeneca’s PARP inhibitor Lynparza in advanced breast cancer

Standard therapy plus abiraterone lowers relative risk of death in men with advanced prostate cancer

Immunotherapy combination offers new hope for women with early stage triple negative breast cancer

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in